Prostate cancer: Estimating the benefits of PSA screening Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Mass Screening
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • Two groundbreaking trials have this year reported conflicting results as to the benefit of screening for prostate cancer. Careful interpretation in the light of contemporary data is needed to reveal the value of this intervention.

publication date

  • June 2009

Research

keywords

  • Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2862723

Digital Object Identifier (DOI)

  • 10.1038/nrurol.2009.95

PubMed ID

  • 19498406

Additional Document Info

start page

  • 301

end page

  • 3

volume

  • 6

number

  • 6